These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 16144652

  • 1. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
    Adachi YU, Yamada S, Satomoto M, Higuchi H, Watanabe K, Kazama T.
    Brain Res Bull; 2005 Oct 15; 67(3):176-81. PubMed ID: 16144652
    [Abstract] [Full Text] [Related]

  • 2. [The effect of isoflurane anesthesia on dopamine release in rat striatum with pretreatment of imipramine].
    Adachi Y, Higuchi H, Watanabe K, Kazama T, Doi M, Sato S.
    Masui; 2006 Apr 15; 55(4):412-8. PubMed ID: 16634541
    [Abstract] [Full Text] [Related]

  • 3. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct 15; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

  • 4. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G.
    Life Sci; 2006 Mar 20; 78(17):1940-4. PubMed ID: 16216278
    [Abstract] [Full Text] [Related]

  • 5. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
    Adachi YU, Yamada S, Satomoto M, Watanabe K, Higuchi H, Kazama T, Doi M, Sato S.
    Brain Res Bull; 2006 May 15; 69(5):593-6. PubMed ID: 16647588
    [Abstract] [Full Text] [Related]

  • 6. Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study.
    Adachi YU, Yamada S, Satomoto M, Higuchi H, Watanabe K, Kazama T, Mimuro S, Sato S.
    Neurochem Int; 2008 Feb 15; 52(3):384-91. PubMed ID: 17719143
    [Abstract] [Full Text] [Related]

  • 7. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M, Leone G, Schilström B, Linnér L, Nomikos G, Hertel P, Silvestrini B, Svensson H.
    Psychopharmacology (Berl); 2001 Dec 15; 159(1):98-104. PubMed ID: 11797076
    [Abstract] [Full Text] [Related]

  • 8. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F, Chalansonnet M, Carabin N, Micillino JC.
    Arch Toxicol; 2006 Oct 15; 80(10):703-12. PubMed ID: 16518643
    [Abstract] [Full Text] [Related]

  • 9. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY, Chai BL, Thompson PA, Yamamoto BK.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1452-61. PubMed ID: 8138957
    [Abstract] [Full Text] [Related]

  • 10. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU, Aramaki Y, Satomoto M, Higuchi H, Watanabe K.
    Neurochem Int; 2003 Jul 15; 43(2):113-9. PubMed ID: 12620279
    [Abstract] [Full Text] [Related]

  • 11. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
    Faro LR, do Nascimento JL, Alfonso M, Durán R.
    Ecotoxicol Environ Saf; 2001 Mar 15; 48(3):263-7. PubMed ID: 11222035
    [Abstract] [Full Text] [Related]

  • 12. Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from striatum of rats.
    Faro LR, Durán R, do Nascimento JL, Alfonso M, Picanço-Diniz CW.
    Ecotoxicol Environ Saf; 1997 Nov 15; 38(2):95-8. PubMed ID: 9417850
    [Abstract] [Full Text] [Related]

  • 13. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 15; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 14. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
    Zelles T, Chernaeva L, Baranyi M, Déri Z, Adam-Vizi V, Vizi ES.
    J Neurosci Res; 1995 Oct 01; 42(2):242-51. PubMed ID: 8568925
    [Abstract] [Full Text] [Related]

  • 15. Postmortem instability of dopamine and its metabolites in rat striatum and limbic forebrain.
    Karolewicz B, Romańska I, Antkiewicz-Michaluk L.
    Pol J Pharmacol; 1998 Oct 01; 50(6):425-9. PubMed ID: 10385925
    [Abstract] [Full Text] [Related]

  • 16. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A, Nissbrandt H.
    Brain Res; 1991 Aug 23; 557(1-2):5-12. PubMed ID: 1720998
    [Abstract] [Full Text] [Related]

  • 17. Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
    Adachi YU, Watanabe K, Higuchi H, Satoh T, Vizi ES.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):61-8. PubMed ID: 11430914
    [Abstract] [Full Text] [Related]

  • 18. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, Kinoshita K.
    Arzneimittelforschung; 1998 Apr 22; 48(4):353-9. PubMed ID: 9608876
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.